Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Free Cash Flow (2016 - 2025)

Historic Free Cash Flow for Fortress Biotech (FBIO) over the last 13 years, with Q3 2025 value amounting to -$6.1 million.

  • Fortress Biotech's Free Cash Flow rose 6726.32% to -$6.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$66.1 million, marking a year-over-year increase of 3531.35%. This contributed to the annual value of -$80.2 million for FY2024, which is 3749.14% up from last year.
  • According to the latest figures from Q3 2025, Fortress Biotech's Free Cash Flow is -$6.1 million, which was up 6726.32% from -$27.6 million recorded in Q2 2025.
  • Fortress Biotech's 5-year Free Cash Flow high stood at -$6.1 million for Q3 2025, and its period low was -$48.2 million during Q1 2022.
  • Its 5-year average for Free Cash Flow is -$29.7 million, with a median of -$27.6 million in 2025.
  • In the last 5 years, Fortress Biotech's Free Cash Flow plummeted by 11678.14% in 2022 and then skyrocketed by 6726.32% in 2025.
  • Fortress Biotech's Free Cash Flow (Quarter) stood at -$40.7 million in 2021, then fell by 17.91% to -$47.9 million in 2022, then rose by 27.06% to -$35.0 million in 2023, then soared by 63.08% to -$12.9 million in 2024, then skyrocketed by 52.66% to -$6.1 million in 2025.
  • Its last three reported values are -$6.1 million in Q3 2025, -$27.6 million for Q2 2025, and -$19.6 million during Q1 2025.